Corvia Medical is funded by Accelmed, Third Rock Ventures, General Catalyst Partners, Lumira Capital, Edwards Lifesciences, and an undisclosed strategic investor. Their support enables us to focus on growing the business and establishing the Corvia Atrial Shunt System as a revolutionary treatment for heart failure.
